Thank you for your participation!
Joseph B. Martin Conference Center
at Harvard Medical School
77 Avenue Louis Pasteur, Boston, MA 02115
About the Conference
The First Stop for Growing Your
The 15th Annual Trans-Pacific Health Sciences Dialogue is a meeting for biopharmaceutical industry executives and business development executives who want to accelerate, explore and develop collaborations and partnerships with their counterparts in the most important Trans-Pacific health care markets including Japan, China, South Korea and North America.
This is a must-attend meeting for executives who have, or want to develop, a Trans-Pacific strategy. The event has developed a well-earned reputation as the best place for biopharma companies seeking to forge Trans-Pacific ventures to start exploring their options. Attendees come away with a broad overview and insights they simply will not get in other meetings.
Take a look at some photos from the 2016 Trans-Pacific Health Sciences Dialogue!
Industry News from FiercePharmaAsia
- FiercePharmaAsia—Ono’s new BMS deal, Eisai’s Lenvima, Sanofi’s Dengvaxia testimonyBristol-Myers Squibb forms new immuno-oncology deal with Ono, Eisai's Lenvima wins NICE backing in kidney cancer, Sanofi tries to persuade Philippines lawmakers that Dengvaxia is safe and works to develop a solution for the fallout, and more.
- Novo and partner Torrent plan major plant expansion in IndiaNovo Nordisk, which relies on Indian drugmaker Torrent Pharmaceuticals to produce much of the insulin it sells in that country, has plans for a major capacity boost there.
Who Should Attend
The Trans-Pacific Health Sciences Dialogue is an event for biopharmaceutical executives, KOLs, select industry advisors and members of the financial community with a strategic interest in Trans-Pacific collaboration or investment.